{
  "openalex_id": "W4282978930",
  "doi": "https://doi.org/10.1158/1538-7445.am2022-161",
  "title": "Abstract 161: Regulation of Abl at mitotic centrosomes and survival by ILK in glioblastoma cells",
  "abstract": "Abstract Many cancer cells possess supernumerary centrosomes, having more than one centrosome at each pole during mitosis which can lead to aberrant mitotic division and cell death. To prevent this fate, cancer cells cluster their centrosomes at two poles during division to divide in a pseudobipolar manner. As the presence of supernumerary centrosomes is rare in normal cells, targeting the declustering of supernumerary centrosomes in cancer cells is a promising strategy for cancer treatment. Integrin-linked kinase (ILK) is an oncogenic protein and chemotherapeutic target shown to be found at the centrosome where it has a role in facilitating centrosome clustering. Inhibition of ILK, via an anti-ILK chemotherapeutic drug QLT-0267, has been shown to increase centrosome declustering causing mitotic arrest and cell death. However, not all cancers cells are susceptible to anti-ILK treatment alone. Therefore, we investigate a combination treatment strategy targeting ILK and another oncogenic kinase, Abelson kinase (Abl). Both ILK and Abl are involved in cancer cell survival, regulated by the same signalling pathways and share common binding partners that occur at the centrosome and are critical for mitosis. The ILK inhibitor QLT-0267 induced a significant sub-G1 peak following propidium iodide FACS analysis and an increase in MTT labelling, indicating that QLT-0267 significantly decreased survival in glioblastoma cell lines. These effects were augmented in the presence of imatinib, an Abl inhibitor. Moreover, QLT-0267 and imatinib, in combination, significantly increased mitotically arrested cells over the ILK inhibitor alone. Increased levels of cytosolic Abl have been associated with its transformative abilities. The ILK inhibitor effects on survival correlated with its ability to decrease cytosolic Abl levels and inhibited Ablâ€™s localization to mitotic centrosomes in dividing glioblastoma cells. These effects were reversed by the proteasomal inhibitor MG132 (a drug that inhibits the degradation of Abl). Together these results indicate that combination treatment with QLT-0267 and imatinib are more effective then QLT-0267 alone at decreasing successful mitoses and survival in glioblastoma cells. Future studies will unravel the relationship between these oncogenic kinases at centrosomes and its effect on cancer cell cycle progression and survival. Citation Format: Jonathan Dresselhuis, Maddisen Brown, Nicole Robinson, Jacqueline Tan, Michael E. Cox, Julia Mills. Regulation of Abl at mitotic centrosomes and survival by ILK in glioblastoma cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 161.",
  "authors": [
    {
      "display_name": "Jonathan Dresselhuis",
      "id": "A5082925087",
      "orcid": "https://orcid.org/0000-0002-9069-264X",
      "institutions": [
        {
          "id": "I125749732",
          "display_name": "Western University",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I24370400",
          "display_name": "Trinity Western University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jonathan Dresselhuis"
    },
    {
      "display_name": "Maddisen Brown",
      "id": "A5067642919",
      "orcid": null,
      "institutions": [
        {
          "id": "I125749732",
          "display_name": "Western University",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I24370400",
          "display_name": "Trinity Western University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Maddisen Brown"
    },
    {
      "display_name": "Nicole Robinson",
      "id": "A5036551641",
      "orcid": "https://orcid.org/0000-0001-6285-6179",
      "institutions": [
        {
          "id": "I4210150180",
          "display_name": "Vancouver Coastal Health Research Institute",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I141074466",
          "display_name": "Vancouver Coastal Health",
          "country_code": "CA",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Nicole Robinson"
    },
    {
      "display_name": "Jacqueline Tan",
      "id": "A5007642003",
      "orcid": null,
      "institutions": [
        {
          "id": "I24370400",
          "display_name": "Trinity Western University",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I125749732",
          "display_name": "Western University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Jacqueline Tan"
    },
    {
      "display_name": "Michael Cox",
      "id": "A5101825863",
      "orcid": "https://orcid.org/0000-0001-6468-6046",
      "institutions": [
        {
          "id": "I141074466",
          "display_name": "Vancouver Coastal Health",
          "country_code": "CA",
          "type": "healthcare"
        },
        {
          "id": "I4210150180",
          "display_name": "Vancouver Coastal Health Research Institute",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Michael E. Cox"
    },
    {
      "display_name": "Julia Mills",
      "id": "A5033601117",
      "orcid": null,
      "institutions": [
        {
          "id": "I24370400",
          "display_name": "Trinity Western University",
          "country_code": "CA",
          "type": "funder"
        },
        {
          "id": "I125749732",
          "display_name": "Western University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Julia Mills"
    }
  ],
  "publication_year": 2022,
  "publication_date": "2022-06-15",
  "type": "article",
  "cited_by_count": 0,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "82",
  "issue": "12_Supplement",
  "first_page": "161",
  "last_page": "161",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C10447061",
      "display_name": "Centrosome",
      "level": 4,
      "score": 0.944155
    },
    {
      "id": "C66417403",
      "display_name": "Integrin-linked kinase",
      "level": 5,
      "score": 0.8045246
    },
    {
      "id": "C93304396",
      "display_name": "Mitosis",
      "level": 2,
      "score": 0.7048536
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.5806054
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.57459295
    },
    {
      "id": "C95444343",
      "display_name": "Cell biology",
      "level": 1,
      "score": 0.50025177
    },
    {
      "id": "C96232424",
      "display_name": "Cancer cell",
      "level": 3,
      "score": 0.49687508
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.4166483
    },
    {
      "id": "C184235292",
      "display_name": "Kinase",
      "level": 2,
      "score": 0.39811072
    },
    {
      "id": "C29537977",
      "display_name": "Cell cycle",
      "level": 3,
      "score": 0.35472184
    },
    {
      "id": "C97029542",
      "display_name": "Protein kinase A",
      "level": 3,
      "score": 0.20292342
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.168273
    },
    {
      "id": "C82495950",
      "display_name": "Cyclin-dependent kinase 2",
      "level": 4,
      "score": 0.08393937
    }
  ],
  "topics": [
    {
      "id": "T12477",
      "display_name": "Toxin Mechanisms and Immunotoxins",
      "score": 0.8635
    },
    {
      "id": "T11215",
      "display_name": "Chronic Myeloid Leukemia Treatments",
      "score": 0.8506
    },
    {
      "id": "T12318",
      "display_name": "Quinazolinone synthesis and applications",
      "score": 0.8282
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.am2022-161",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:09:41.718033",
  "source_database": "OpenAlex"
}